These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1058731)

  • 1. Antibiotics and endotoxic shock.
    McCabe WR
    Bull N Y Acad Med; 1975 Oct; 51(9):1084-95. PubMed ID: 1058731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapy for gram-negative bacteremia.
    Calandra T; Cometta A
    Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gram negative sepsis and shock.
    Landesman SH; Gorbach SL
    Orthop Clin North Am; 1978 Jul; 9(3):611-25. PubMed ID: 358039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoproterenol in the treatment of shock due to bacteremia with gram-negative pathogens.
    Kardos GG
    N Engl J Med; 1966 Apr; 274(16):868-73. PubMed ID: 17926865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the anti-endotoxic effects of polymyxin-E (colistin) in dogs with naturally occurred endotoxic shock.
    Sentürk S
    J Vet Pharmacol Ther; 2005 Feb; 28(1):57-63. PubMed ID: 15720516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic therapy in septic shock.
    Roach AC
    Crit Care Nurs Clin North Am; 1990 Jun; 2(2):179-86. PubMed ID: 2192726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Ohlsson K; Björk P; Bergenfeldt M; Hageman R; Thompson RC
    Nature; 1990 Dec; 348(6301):550-2. PubMed ID: 2147233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-negative endotoxins and staphylococcal toxic shock syndrome.
    de Azavedo JC; Hartigan PJ; de Saxe M; Arbuthnott JP
    Prog Clin Biol Res; 1985; 189():419-32. PubMed ID: 4048216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin release after antibiotic treatment and its potential pathogenetic role in coagulative disorders of patients with gram-negative sepsis.
    Miragliotta G
    J Chemother; 1991 Jan; 3 Suppl 1():69-72. PubMed ID: 12041790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin B: an ode to an old antidote for endotoxic shock.
    Bhor VM; Thomas CJ; Surolia N; Surolia A
    Mol Biosyst; 2005 Sep; 1(3):213-22. PubMed ID: 16880985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and conduct of clinical trials: development of a clinical study based on animal data.
    Hinshaw LB
    Prog Clin Biol Res; 1988; 264():51-60. PubMed ID: 3289034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
    Morrison DC
    Prog Clin Biol Res; 1998; 397():199-207. PubMed ID: 9575560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
    Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
    Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.